Trump administration: Drugmakers that hiked prices may create 'tipping point'
The Trump administration said Monday it is closely watching reports of drug increases. (The White House)
The secretary of HHS had a direct message on Monday for the pharmaceutical companies that have hiked the prices of their products in recent months: The presidentsees you.
Speaking at an event hosted by the 340B Coalition, he alluded to a tweet earlier in the day from the commander-in-chiefspecifically calling out drug giant Pfizer and other drug companies for hiking their prices in recent months.
The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.